NEWSROOM
MediTox received funds from the program Marketing – Challenge I – participation in foreign events co-funded by the European Union.
The investment plan for period 2023 - 2024 includes:
- Complete change of technologies and processes in the sense of energy savings and reduction of carbon footprint
- Expanding of experimental capacities for studies in cats
- Major reconstruction of multipurpose experimental rooms for non-rodent species
- Relocation and rebuilding of lab of application forms
- New laboratory equipment
New methods and models:
A team of experts is working on the development and implementation of the following tests and models:
- chronic glaucoma in rabbits, osteoarthritis in rabbits, priodontitis in dogs, permethrine intoxication therapy in cats, endometritis in rabbits
Internal education program 2024
| Internal education program 2024 | |
|---|---|
| Date | Topic |
| March 2024 | Atelica® CH93 - specifics of the new biochemistry analyzer |
| April 2024 | Liquid Jet Injector Device - pilot study of the use of a special injector for intradermal administration in cats |
| May 2024 | GLP training |
| June 2024 | Characteristics of the findings in the tox study 17/22/L and 18/22/L after repeated intramuscular administration |
| September 2024 | GLP training |
| October 2024 | Findings of national inspection bodies, summary of findings of internal inspections of studies, CAPA |
| November 2024 | Model of permethrin intoxication in cats |
